Virtus Pharmaceuticals Recalls Virt-Nate Tablets Due to Incorrect Folate Labeling
Virtus Pharmaceuticals is recalling Virt-Nate Tablets because product labels do not show the correct Dietary Folate Equivalents (DFEs) as calculated by the product formulation. This could lead to inaccurate folate intake.
Lower-risk recall
Virtus Pharmaceuticals, LLC has decided to initiate a recall of the following products : Virt-Nate Tablets and Virt Gard Tablets because product labels do not reflect the correct amount of Dietary Folate Equivalents (DFEs) calculated based on the product formulation.
Contact the company
What happened, in plain English
Virtus Pharmaceuticals is recalling Virt-Nate Tablets because the labels do not correctly state the Dietary Folate Equivalents (DFEs) for the product. This could result in users taking too much or too little folate, which is important for certain health conditions. Read more at govinfonow.com/recall/18770-virtus-pharmaceuticals-recalls-virt-nate-tablets-due-to-incorrect-folate.
Source Summary by GovInfoNow · govinfonow.com/recall/18770-virtus-pharmaceuticals-recalls-virt-nate-tablets-due-to-incorrect-folate · Updated October 6, 2026 · FDA enforcement record: FDA #F-1932-2018
Cite this page
“Virtus Pharmaceuticals Recalls Virt-Nate Tablets Due to Incorrect Folate Labeling.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/18770-virtus-pharmaceuticals-recalls-virt-nate-tablets-due-to-incorrect-folate. Based on FDA recall #F-1932-2018 (https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-1932-2018%22&limit=1).
Why it’s dangerous
The tablets' labels do not accurately reflect the Dietary Folate Equivalents (DFEs) as calculated by the product formulation. This means users might be taking more or less folate than intended, which could affect their health, especially if they have specific dietary requirements.
Who’s affected
People who own Virt-Nate Tablets with lot numbers M185860 (expiring Dec 2018) or M1903000 (expiring Apr 2019) are affected. Those with specific dietary needs, like pregnant individuals or those managing folate levels, are at higher risk.
How to tell if you have this one
Check for lot numbers M185860 (expiring Dec 2018) or M1903000 (expiring Apr 2019) on the Virt-Nate Tablets packaging. The product comes in 100 tablets per bottle.
- Brand
Virtus Pharmaceuticals- Category
Food
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Terminated- Distribution
Virt Nate: Arizona, Colorado, Illinois, Indiana, Michigan, Minnesota, Missouri, Mississippi, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Texas, Virginia, Vermont and Wisconsin. Virt Gard: Arizona, California, Colorado, Florida, Georgia, Iowa, Illinois, Kentucky, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Texas, Virginia and West Virginia.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| F-1932-2018 | Virt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/Bottle; Lot# M185860 Expiration Date: 12/2018 Lot# M1903000 Expiration Date: 4/2019 | 2209 Bottles |
| F-1933-2018 | Virt Gard Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/Bottle; Lot# M187380 Expiration Date: 1/2019 Lot# M192410 Expiration Date: 6/2019 Lot# M192410A Expiration Date: 6/2019 | 11926 Bottles |
What to do — step by step
Check Product Label
Look for lot numbers M185860 (expiring Dec 2018) or M1903000 (expiring Apr 2019) on the Virt-Nate Tablets packaging.
Where it went and when
Where it was distributed
Distributed in 26 states.
FDA distribution: “Virt Nate: Arizona, Colorado, Illinois, Indiana, Michigan, Minnesota, Missouri, Mississippi, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Texas, Virginia, Vermont and Wisconsin. Virt Gard: Arizona, California, Colorado, Florida,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, Vermont, Virginia, West Virginia, Wisconsin.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest food recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #F-1932-2018 (August 3, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for F-1932-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.